Characterizing Induced Pluripotent Stem Cells and Derived Cardiomyocytes: Insights from Nano Scale Mass Measurements and Mechanical Properties
Overview
Overview
Journal
Nanoscale Adv
Publisher
Royal Society of Chemistry
Specialty
Biotechnology
Date
2024 Feb 15
PMID
38356620
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Our study reveals that the nano-mechanical measures of elasticity and cell mass change significantly through induced pluripotent stem cell (iPSC) differentiation to cardiomyocytes, providing a reliable method to evaluate such processes. The findings support the importance of identifying these properties, and highlight the potential of AFM for comprehensive characterization of iPSC at the nanoscale.
References
1.
Ginzberg M, Kafri R, Kirschner M
. Cell biology. On being the right (cell) size. Science. 2015; 348(6236):1245075.
PMC: 4533982.
DOI: 10.1126/science.1245075.
View
2.
Suresh S
. Biomechanics and biophysics of cancer cells. Acta Biomater. 2007; 3(4):413-38.
PMC: 2917191.
DOI: 10.1016/j.actbio.2007.04.002.
View
3.
Mummery C, Zhang J, Ng E, Elliott D, Elefanty A, Kamp T
. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012; 111(3):344-58.
PMC: 3578601.
DOI: 10.1161/CIRCRESAHA.110.227512.
View
4.
Qiu Y, Chien C, Maroulis B, Bei J, Gaitas A, Gong B
. Extending applications of AFM to fluidic AFM in single living cell studies. J Cell Physiol. 2022; 237(8):3222-3238.
PMC: 9378449.
DOI: 10.1002/jcp.30809.
View
5.
Redfern W, Carlsson L, Davis A, Lynch W, Mackenzie I, Palethorpe S
. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003; 58(1):32-45.
DOI: 10.1016/s0008-6363(02)00846-5.
View